AMA Approved New CPT Codes for Nerve Stimulation

The American Medical Association finalized new codes to standardize billing for hypoglossal nerve stimulation therapy.

Updated on Oct. 1, 2026 in Sleep Disorders

Bold flat-color editorial illustration depicting a stylized metallic medical implant, evoking the precision of medical billing standardization.
The American Medical Association has finalized new Category I CPT codes for hypoglossal nerve stimulation, streamlining insurance reimbursement for obstructive sleep apnea treatments. AI Illustration. Upload story photo >

Live Poll

Should medical device companies prioritize creating new coding standards to simplify hospital and physician administrative tasks?

The American Medical Association CPT Editorial Panel has approved new Category I CPT codes for hypoglossal nerve stimulation, including the Inspire V system. These codes are designed to establish a consistent path for coding and reimbursement for the obstructive sleep apnea treatment.

Why it matters

Standardizing these codes provides a clearer framework for medical providers and insurers, ensuring the treatment is coded accurately within the healthcare system. This shift supports the long-term integration of established sleep apnea therapies into clinical billing practices.

The new Category I CPT codes will apply to hypoglossal nerve stimulation, a technology used by over 140,000 patients over the past 10 years. Final payment valuations for these codes are still under investigation by federal regulators.

The players

American Medical Association

This professional association is the largest physician organization in the United States and maintains the Current Procedural Terminology (CPT) code set.

Centers for Medicare & Medicaid Services

This federal agency within the United States Department of Health and Human Services oversees national health programs and determines physician payment rates.

Inspire Medical Systems

Based in Minneapolis, this medical technology company specializes in the development of innovative treatments for obstructive sleep apnea.

The details

The Centers for Medicare & Medicaid Services will now coordinate with the RUC to evaluate physician time and practice expenses associated with the procedure. Specialty societies will survey their members to provide data that informs the final valuation process.

Timeline

  1. July 2027: CMS is expected to publish proposed valuations for the new codes.

  2. November 2027: CMS is expected to publish final valuations for the codes.

  3. January 1, 2028: The new Category I CPT codes will take effect.

The Big Picture

This approval follows the standardized administrative cycle of the AMA CPT Editorial Panel's code revision process. It represents the latest institutional update in a recurring system used to integrate evolving medical technologies into national billing standards.

The introduction of standardized codes may simplify the billing and insurance authorization process for patients seeking nerve stimulation therapy. Patients should consult with their providers to understand how these coding changes might affect coverage and out-of-pocket costs after 2028.

The takeaway

The move to update coding standards reflects the maturation of nerve stimulation as a recognized medical intervention for sleep apnea. Patients and providers should prepare for these administrative changes to ensure billing continuity as the new regulations phase in.

What happens next

CMS will issue proposed valuations for the new codes in July 2027, followed by final valuations in November 2027.

Further reading

For more information on the management of sleep apnea, visit the Sleep Disorders section.

More information

Find further details on treatment options and system technology on the Inspire Medical Systems company information website.

Live Poll

Should medical device companies prioritize creating new coding standards to simplify hospital and physician administrative tasks?